Gastric Antisecretory Drug Global Market Poised To Reach $19.97 Billion By 2029

LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Drivers, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

The gastric antisecretory drug market has been on a robust growth trajectory in the past few years. With a market size projected to escalate from $14.87 billion in 2024 to $15.78 billion in 2025, the industry is set to register a compound annual growth rate CAGR of 6.2%. Factors such as rising stress levels, sedentary lifestyles, increased cases of helicobacter pylori infections, supportive government healthcare policies, burgeoning medical tourism, and the expansion of e-commerce and online pharmacies have all contributed significantly to the growth during this historic period.

What Does The Future Hold For The Gastric Antisecretory Drug Market?
The gastric antisecretory drug market is anticipated to exhibit solid growth in the forthcoming years, projected to reach $19.97 billion by 2029 at a CAGR of 6.1%. The future growth is expected to be fueled by a blend of factors such as the rising prevalence of gastrointestinal disorders, an aging population, increased mindfulness about digestive health, expanding healthcare infrastructure, and higher consumption of fast and processed foods. Other major trends in the forecast period encompass widespread use of NSAIDs, availability of over-the-counter antisecretory drugs, advancements in drug delivery systems, availability of generic drugs, and breakthroughs in combination therapies.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24222&type=smp

What Factors Are Driving The Gastric Antisecretory Drug Market?
One of the key growth drivers of the gastric antisecretory drug market is the escalating prevalence of gastrointestinal disorders. These disorders, affect the digestive tract, which includes the intestines, stomach, and other associated organs, and lead to symptoms like pain, bloating, and altered bowel movements. The surge in gastrointestinal disorders can be attributed predominantly to poor dietary habits, with an excess intake of processed foods and insufficient fiber upsetting the balance of gut microbiota and triggering impaired digestion.

Here, the role of gastric antisecretory drugs becomes critical, as excessive stomach acid can erode the protective lining of the gastrointestinal tract, causing irritation or injury. These drugs help mitigate such damages by curbing acid production. As identified in a report published by ScienceDirect in May 2025, about 23.5 million gastrointestinal endoscopies were performed in 2022. Hence, the rising cases of gastrointestinal disorders are poised to spur the growth of the gastric antisecretory drug market.

Who Are The Key Players In The Gastric Antisecretory Drug Market?
The gastric antisecretory drug market is home to major companies like Pfizer Inc., Bayer AG, AstraZeneca plc, Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, Chemo Biological, Spansules Pharmatech Pvt. Ltd., Phoenix Biologicals Pvt. Ltd., Centurion Remedies Private Limited, Solitaire Pharmacia Pvt. Ltd., Shreeji Pharma International, Estrellas Life Sciences Private Limited, 3s Corporation, Actiza Pharmaceutical Private Limited, Lark Laboratories, Cytonova Labs International Private Limited, Luckys Pharma Lab Pvt. Ltd., Lexicare Pharma Pvt. Ltd., and Mustcure Healthcare LLP

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gastric-antisecretory-drug-global-market-report

What Are The Emerging Trends In The Gastric Antisecretory Drug Market?
Major industry players are now focusing on the development of advanced products, antisecretory compounds in particular, to provide long-lasting relief to patients. These compounds inhibit or decrease the secretion of bodily fluids, especially gastric acid, by targeting certain cellular paths or receptors.

How Is The Gastric Antisecretory Drug Market Segmented?
The gastric antisecretory drug market is segmented based on –
1 Drug Class: Proton Pump Inhibitors PPIs, H2 Receptor Antagonists, Antacids, Prostaglandin Analogs
2 Route Of Administration: Oral, Intravenous, Topical
3 Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4 Application: Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome, Other Applications

Subsegments:
1 PPIs: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole
2 H2 Receptor Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3 Antacids: Magnesium Hydroxide, Calcium Carbonate, Aluminum Hydroxide, Sodium Bicarbonate, Combination Antacids
4 Prostaglandin Analogs: Misoprostol, Enprostil

What Are The Regional Insights In The Gastric Antisecretory Drug Market?
North America emerged as the largest region in the gastric antisecretory drug market in 2024. However, it is Asia-Pacific that is expected to outpace all other regions in the future, with the most rapid growth forecast for the upcoming years. The regions covered in this gastronomic antisecretory drug market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Gastric Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Diagnostic Procedure Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Gastric Volvulus Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

About The Business Research Company.
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.